Mach7 Technologies Ltd. · ASX:M7T
Mach7 Technologies — Investor Presentation (June 2021)
20 slides from Mach7 Technologies's investor presentation, Jun 3, 2021
Slide 1: Mach7 Technologies Investor Presentation
Mach7 Technologies Investor Presentation 3 June, 2021 Mach7 Technologies – All information is proprietary and confidential unless otherwise specified
Slide 2: Summary of information
Summary of information: This presentation contains general and background information about Mach7 Technologies Limited (“M7T”) activities current as at the date of the presentation and should not be considered to be comprehensive or to comprise all the information that an investor should consider wh
Slide 3: Enterprising Imaging Solution Provider
Enterprising Imaging Solution Provider Mach7 Technologies develops innovative image management and viewing solutions for healthcare providers globally. Our solutions form the core of an integrated enterprise imaging ecosystem. We give healthcare organizations the independence and flexibility to depl
Slide 4: Cash on hand $18M, no debt, no capitalized R&D
2007 2010 2012 2016 2018 2019 2020 Mach7 Founded • First Pilots Deployed • First Commercial Wins Listed on ASX (M7T) New Diagnostic, • Completes Client • Cloud Deployments • Revenue Phase Begins Connected Health Outlook Acquisition • USA & Middle East and AI Solutions • Achieves Profitability • Cash
Slide 5: Management team
Mike Lampron Jenni Pilcher CFO, COMPANY Ravi Krishnan MANAGING DIRECTOR, FOUNDER, GM Asia SECRETARY CEO 10+ years executive experience 20+ years experience in in ASX-listed healthcare Founding partner of Mach7 business and operational companies Technologies management for HCIT Former CFO and
Slide 6: Board of directors
Eliot Siegel, MD David Chambers NON-EXECUTIVE DIRECTOR CHAIRMAN Thought leader in the world 30+ years’ extensive experience of radiology and imaging in HCIT and Life Science informatics. Professor and industry. Vice Chair at the University Former CEO of Promedicus of Maryland School of (ASX:PM
Slide 7: We help healthcare providers
We help healthcare providers: Drive workflow efficiency Achieve profound operational cost savings Leverage their existing IT solution investments Improve the experience for patients and medical professionals, leading to better patient outcomes Mach7 Technologies – All information is proprietary and
Slide 8: Enterprise Viewing, Enterprise Data Management, Enterprise PACS
Enterprise Viewing Enterprise Data Management Enterprise PACS • Leading industry zero-footprint • Vendor neutral archiving and image data • Enterprise diagnostic viewing and “eUnity” Enterprise and management enterprise data management solution Diagnostic Viewers • Consolidates all imaging data rega
Slide 9: Solves Immediate Needs, Fits Individual Needs, Lasting Technology
Solves Immediate Needs Fits Individual Needs Lasting Technology Cutting Edge of Technology Designed for the Enterprise Flexible Workflows Flexible Contract Terms Customer Partnerships Agile Global Company Mach7 Technologies – All information is proprietary and confidential unless otherwise specified
Slide 10: Integrated Delivery Networks, Centers of Excellence, International hospital authorities
• Integrated Delivery Networks • Centers of Excellence • International hospital • Imaging Centers authorities and health systems • Telehealth service providers • Regional and community • Integration platform for hospital systems external systems (EMR, VR, • Academic medical institutions Image Sharin
Slide 11: Hospital systems around the world employ Mach7 Technologies
CUSTOMER FOOTPRINT - 14 COUNTRIES GLOBALLY United States Canada China United Kingdom Hong Kong The Netherlands Singapore Philippines Saudi Arabia Indonesia Vietnam France Italy Qatar *Includes eUnity installations Hospital systems around the world employ Mach7 Technologies Mach7 Technologies – All i
Slide 12: More than 150 customers spanning 14 countries globally
More than 150 customers spanning 14 countries globally. Hospitals and healthcare entities around the world deploy Mach7’s solutions and innovative technologies. We have built a global network of diverse customers that range from expansive Integrated Delivery Networks, National Health Systems, medica
Slide 13: Partnerships focused on Meaningful Value to Support Patient Care
Partnerships focused on Meaningful Value to Support Patient Care Augmenting and expanding Mach7’s Enterprise Imaging Solution through innovative and collaborative partnerships designed to provide elevated value to healthcare organizations around the globe.
Slide 14: $4.4Bn global imaging market; Radiology IT $2.6Bn
$4.4Bn global imaging market; Radiology IT $2.6Bn - CAGR 2.3% (forecast); Table 2.3 Mach7 competes in all segments of the Radiology IT World Market for Radiology IT Total market, except Standalone RIS & Image Exchange Revenue (US$m) CAGR 2019 2020* 2021* 2022* 2023* 2024* (20-24) Radiology IT is a s
Slide 15: Services comprise bulk of market (61%)
Services comprise bulk of market (61%) – Mach7 services approx 50% of revenue Most (86%) deployments are on-premise, cloud uptake still slow Capex revenue models still dominant Radiology IT sales (89%) over SAAS Table 6.2 World Market for Product 2019 % Radiology IT Hardware 266.6 10% 2019 Com
Slide 16: Two sales models – Capital License and Subscription License
Two sales models – Capital License (“Capex”) and Subscription License (“SAAS”) Capital License Subscription License Activity Revenue Recognition Example Activity Revenue Recognition Example License Granted (perpetual or 5 year term) License Granted (subscription) Software is delivered 100% License F
Slide 17: Strong SAAS revenue growth – 47%
SAAS / Support Revenue 12.0 M Strong SAAS revenue growth – 47% CAGR (last 3 years), 130 Customers 10.0 M Forecast ~$10.5M-$11M FY2021 8.0 M In addition to the Annuity Revenue, Mach7 earns revenue from: 6.0 M • Software License Fees recognised 100% at time of delivery ($10.4M 4.0 M FY2020, $3.1
Slide 18: Sales orders drives software fees and future annuity revenue
Sales orders drives software fees and future annuity revenue Highlights: • Sales growth is continuing, despite COVID-19 • $23.6M (TCV^) sales orders Q3 YTD – up 94% on last year. Sales orders include: • Trinity ($5.3M) - Capital/Perpetual /7 yrs* • Adventist ($8M) - Capital/Perpetual /5 yrs* • HAHK
Slide 19: Imaging Market outlook
Imaging Market • The uncertainty and volatility brought on by the pandemic, hugely disruptive for the imaging IT market, is receding. • There is pressure on imaging IT to deal with removing barriers for remote diagnosis for Radiologists. • Heightened focus on IT healthcare spend generally will drive
Slide 20: Thank you
For more information, contact: Thank you Jenni Pilcher CFO, Mach7 jenni.pilcher@mach7t.com Andrew Keys Investor Relations andrew.keys@keysthomas.com Registered Office: Tower 4 | 727 Collins Street Docklands, 3008 This presentation has been approved for ASX lodgment by the Company Secretary and CEO,
Mach7 Technologies — Investor Presentation (June 2021) on 6ix